首頁 > 市場調查報告書 > 醫療設備

透析設備

市場調查報告書

商品編碼

1922385

日本血液分離術市場報告：按組件、產品、技術、流程、應用、最終用戶和地區分類（2026-2034 年）

Japan Apheresis Market Report by Component (Plasma, Platelets, Leukocytes, Lymphocytes, RBC's ), Product, Technology, Procedure, Application, End User, and Region 2026-2034

出版日期: 2026年01月01日 | 出版商:

IMARC | 英文 118 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2025年，日本血液分離術市場規模達1.513億美元。 IMARC Group預測，到2034年，該市場規模將達到2.56億美元，2026年至2034年的複合年成長率（CAGR）為6.02%。推動市場成長的關鍵因素包括：癌症、自體免疫疾病和血液相關疾病等慢性病發病率的上升趨勢；血液分離術設備的快速技術進步；醫護人員和患者對血液分離術益處的認知不斷提高；以及對醫療基礎設施的大量投資。

血液分離術是一種用於治療目的的醫療程序，旨在從捐血者或患者體內分離並去除特定的血液成分。該過程使用稱為血液分離機的精密儀器，選擇性地提取和保存血液成分，例如血漿、血小板、紅血球和白血球。根據目標成分的不同，分離方法可以是離心或過濾。血液分離術的主要治療應用之一是治療各種疾病，包括自體免疫、血液系統疾病和神經系統疾病。例如，在多發性硬化症和重症肌無力等自體免疫疾病中，血液分離術可以去除患者血液中的有害抗體，從而減輕疾病的影響。同樣，在白血病等血液系統疾病中，血液分離術可以幫助收集用於治療或移植的特定血液成分。此外，血液分離術在捐血過程中也發揮著重要作用，它允許收集各種醫療程序所需的特定成分，同時將剩餘成分輸回捐血。這種有針對性地採集血液成分的方法提高了捐血效率，並確保了醫療干預所需的血液製品的穩定和多樣化供應。不斷發展的血液成分分離術持續推動與治療和捐血相關的醫療實踐，為臨床醫生提供了強大的工具，使其能夠選擇性地管理血液成分，從而造福面臨各種健康挑戰的患者。

日本血液分離術市場的發展趨勢：

日本市場的主要驅動力是不斷擴展的治療應用。血液分離設備技術的快速發展顯著促進了市場成長。設備設計、自動化和血液成分分離精度的持續創新，提高了血液分離術的效率和安全性，使其更易於獲取，也更受醫療機構的青睞。這些技術進步也縮短了手術時間，提高了患者的舒適度，進一步促進了血液分離術在臨床環境中的應用。此外，慢性病和自體免疫疾病的日益普遍也推動了對血液分離術的需求。癌症、自體免疫疾病和血液系統疾病等需要有針對性地移除或收集特定血液成分，以控制症狀或增強治療效果。血液分離術作為一種重要的治療性介入手段，能夠選擇性地提取與疾病相關的成分，從而有助於疾病管理和改善患者預後。隨著慢性病負擔的不斷加重，預計血液分離術作為治療選擇的需求將會成長。此外，血液分離術治療應用範圍的不斷擴大也提升了其市場潛力。血液分離術的應用範圍正從傳統領域擴展到包括神經病學、腎臟病學和血液病學在內的多個醫學領域。這種應用的多元化使血液分離術成為各種醫療環境中用途廣泛且實用的工具，從而促進了市場的持續成長。此外，醫療專業人員對血液分離術在治療多種疾病方面的益處認知的不斷提高，也進一步推動了其應用。

本報告解答的關鍵問題

日本血液分離術市場目前發展如何？您預計未來幾年它將如何發展？
新冠疫情對日本血液分離術市場產生了哪些影響？
日本血液分離術市場按市場組成部分是如何分類的？
日本血液分離術市場的產品區隔如何？
日本血液分離術市場依技術分類是怎樣的？
日本血液分離術市場依手術項目分類的組成是怎樣的？
日本血液分離術市場按應用領域是如何分類的？
日本血液分離術市場依最終用戶分類的組成是怎樣的？
日本血液分離術市場價值鏈的各個階段有哪些？
日本血液分離市場的主要促進因素和挑戰是什麼？
日本血液分離術市場的結構是怎麼樣的？主要參與者有哪些？
日本血液分離術市場的競爭程度如何？

Japan apheresis market size reached USD 151.3 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 256.0 Million by 2034, exhibiting a growth rate (CAGR) of 6.02% during 2026-2034 . The increasing incidence of chronic diseases such as cancer, autoimmune disorders, and blood-related conditions, the rapid technological advancements in apheresis equipment, the rising awareness among healthcare professionals and patients about the benefits of apheresis procedures, and the heavy investments in healthcare infrastructure are some of the factors propelling the market.

Access the full market insights report Request Sample

Apheresis, a medical procedure with therapeutic applications, involves the separation and removal of specific blood components from a donor or patient. The process utilizes a sophisticated machine known as an apheresis machine, which allows for the selective extraction and retention of blood components, such as plasma, platelets, red blood cells, or white blood cells. This separation is achieved through centrifugation or filtration, depending on the targeted blood component. One of the primary therapeutic applications of it is in the treatment of various medical conditions, including autoimmune disorders, hematologic diseases, and neurological disorders. For example, in autoimmune diseases like multiple sclerosis or myasthenia gravis, apheresis can remove harmful antibodies from the patient's blood, mitigating the impact of the disease. Similarly, in hematologic disorders like leukemia, apheresis aids in collecting specific blood components for therapeutic use or transplantation. Additionally, it plays a crucial role in blood donation processes, allowing for the collection of specific components needed for various medical treatments while returning the remaining components to the donor. This targeted blood component collection enhances the efficiency of blood donation practices, ensuring a steady and diverse supply of blood products for medical interventions. The evolving field of apheresis continues to contribute to advancements in therapeutic and donation-related medical practices, providing clinicians with a powerful tool to selectively manage blood components to benefit patients facing a spectrum of health challenges.

JAPAN APHERESIS MARKET TRENDS:

The market in Japan is majorly driven by the expanding scope of therapeutic applications. In line with this, the rapid advancements in apheresis machine technologies contribute significantly to market growth. Continuous innovations in device design, automation, and precision in blood component separation enhance the efficiency and safety of apheresis procedures, making them more accessible and attractive to healthcare providers. These technological enhancements also lead to reduced procedure times and improved patient comfort, further driving the adoption of apheresis in clinical settings. Furthermore, the rising prevalence of chronic and autoimmune diseases fuels the demand for apheresis procedures. Conditions such as cancer, autoimmune disorders, and hematologic diseases often require targeted removal or collection of specific blood components to manage symptoms or facilitate treatments. Apheresis serves as a crucial therapeutic intervention by allowing the selective extraction of disease-related components, contributing to disease management and improving patient outcomes. As the burden of chronic diseases continues to increase, the demand for apheresis procedures as a therapeutic option is expected to grow. Besides, the widespread therapeutic applications for apheresis broaden its market potential. Beyond traditional uses, apheresis is finding applications in neurology, nephrology, and hematology, among other medical specialties. This diversification of applications positions apheresis as a versatile and valuable tool in various healthcare scenarios, contributing to its sustained market growth. Additionally, the growing awareness among healthcare professionals about the benefits of apheresis in managing a wide range of medical conditions further propels its adoption.

JAPAN APHERESIS MARKET SEGMENTATION:

Component Insights:

To get detailed segment analysis of this market Request Sample
Plasma (Plasmapheresis)
Platelets (Plateletpheresis)
Leukocytes (Leukapheresis or Leukopheresis)
Lymphocytes (Lymphopheresis or Lymphapheresis)
RBC's (Erythropheresis)
Plasma (Plasmapheresis)
Platelets (Plateletpheresis)
Leukocytes (Leukapheresis or Leukopheresis)
Lymphocytes (Lymphopheresis or Lymphapheresis)
RBC's (Erythropheresis)

Product Insights:

Devices
Disposables and Reagents
Software
Devices
Disposables and Reagents
Software

Technology Insights:

Centrifugation
Membrane Separation
Selective Adsorption
Centrifugation
Membrane Separation
Selective Adsorption

Procedure Insights:

Donor/Automated Apheresis
Therapeutic Apheresis
Donor/Automated Apheresis
Therapeutic Apheresis

Application Insights:

Renal Disorders
Hematological Disorders
Neurological Disorders
Autoimmune Disorders
Others
Renal Disorders
Hematological Disorders
Neurological Disorders
Autoimmune Disorders
Others

End User Insights:

Blood Centers
Hospitals
Others
Blood Centers
Hospitals
Others

Regional Insights:

To get detailed regional analysis of this market Request Sample
Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

KEY QUESTIONS ANSWERED IN THIS REPORT
How has the Japan apheresis market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan apheresis market?
What is the breakup of the Japan apheresis market on the basis of component?
What is the breakup of the Japan apheresis market on the basis of product?
What is the breakup of the Japan apheresis market on the basis of technology?
What is the breakup of the Japan apheresis market on the basis of procedure?
What is the breakup of the Japan apheresis market on the basis of application?
What is the breakup of the Japan apheresis market on the basis of end user?
What are the various stages in the value chain of the Japan apheresis market?
What are the key driving factors and challenges in the Japan apheresis?
What is the structure of the Japan apheresis market and who are the key players?
What is the degree of competition in the Japan apheresis market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Apheresis Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Apheresis Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Apheresis Market - Breakup by Component

6.1 Plasma (Plasmapheresis)
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Forecast (2026-2034)
6.2 Platelets (Plateletpheresis)
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Forecast (2026-2034)
6.3 Leukocytes (Leukapheresis or Leukopheresis)
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2020-2025)
- 6.3.3 Market Forecast (2026-2034)
6.4 Lymphocytes (Lymphopheresis or Lymphapheresis)
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2020-2025)
- 6.4.3 Market Forecast (2026-2034)
6.5 RBC's (Erythropheresis)
- 6.5.1 Overview
- 6.5.2 Historical and Current Market Trends (2020-2025)
- 6.5.3 Market Forecast (2026-2034)

7 Japan Apheresis Market - Breakup by Product

7.1 Devices
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 Disposables and Reagents
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)
7.3 Software
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2020-2025)
- 7.3.3 Market Forecast (2026-2034)

8 Japan Apheresis Market - Breakup by Technology

8.1 Centrifugation
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Forecast (2026-2034)
8.2 Membrane Separation
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Forecast (2026-2034)
8.3 Selective Adsorption
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2020-2025)
- 8.3.3 Market Forecast (2026-2034)

9 Japan Apheresis Market - Breakup by Procedure

9.1 Donor/Automated Apheresis
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2020-2025)
- 9.1.3 Market Forecast (2026-2034)
9.2 Therapeutic Apheresis
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2020-2025)
- 9.2.3 Market Forecast (2026-2034)

10 Japan Apheresis Market - Breakup by Application

10.1 Renal Disorders
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2020-2025)
- 10.1.3 Market Forecast (2026-2034)
10.2 Hematological Disorders
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2020-2025)
- 10.2.3 Market Forecast (2026-2034)
10.3 Neurological Disorders
- 10.3.1 Overview
- 10.3.2 Historical and Current Market Trends (2020-2025)
- 10.3.3 Market Forecast (2026-2034)
10.4 Autoimmune Disorders
- 10.4.1 Overview
- 10.4.2 Historical and Current Market Trends (2020-2025)
- 10.4.3 Market Forecast (2026-2034)
10.5 Others
- 10.5.1 Historical and Current Market Trends (2020-2025)
- 10.5.2 Market Forecast (2026-2034)

11 Japan Apheresis Market - Breakup by End User

11.1 Blood Centers
- 11.1.1 Overview
- 11.1.2 Historical and Current Market Trends (2020-2025)
- 11.1.3 Market Forecast (2026-2034)
11.2 Hospitals
- 11.2.1 Overview
- 11.2.2 Historical and Current Market Trends (2020-2025)
- 11.2.3 Market Forecast (2026-2034)
11.3 Others
- 11.3.1 Historical and Current Market Trends (2020-2025)
- 11.3.2 Market Forecast (2026-2034)

12 Japan Apheresis Market - Breakup by Region

12.1 Kanto Region
- 12.1.1 Overview
- 12.1.2 Historical and Current Market Trends (2020-2025)
- 12.1.3 Market Breakup by Component
- 12.1.4 Market Breakup by Product
- 12.1.5 Market Breakup by Technology
- 12.1.6 Market Breakup by Procedure
- 12.1.7 Market Breakup by Application
- 12.1.8 Market Breakup by End User
- 12.1.9 Key Players
- 12.1.10 Market Forecast (2026-2034)
12.2 Kansai/Kinki Region
- 12.2.1 Overview
- 12.2.2 Historical and Current Market Trends (2020-2025)
- 12.2.3 Market Breakup by Component
- 12.2.4 Market Breakup by Product
- 12.2.5 Market Breakup by Technology
- 12.2.6 Market Breakup by Procedure
- 12.2.7 Market Breakup by Application
- 12.2.8 Market Breakup by End User
- 12.2.9 Key Players
- 12.2.10 Market Forecast (2026-2034)
12.3 Central/ Chubu Region
- 12.3.1 Overview
- 12.3.2 Historical and Current Market Trends (2020-2025)
- 12.3.3 Market Breakup by Component
- 12.3.4 Market Breakup by Product
- 12.3.5 Market Breakup by Technology
- 12.3.6 Market Breakup by Procedure
- 12.3.7 Market Breakup by Application
- 12.3.8 Market Breakup by End User
- 12.3.9 Key Players
- 12.3.10 Market Forecast (2026-2034)
12.4 Kyushu-Okinawa Region
- 12.4.1 Overview
- 12.4.2 Historical and Current Market Trends (2020-2025)
- 12.4.3 Market Breakup by Component
- 12.4.4 Market Breakup by Product
- 12.4.5 Market Breakup by Technology
- 12.4.6 Market Breakup by Procedure
- 12.4.7 Market Breakup by Application
- 12.4.8 Market Breakup by End User
- 12.4.9 Key Players
- 12.4.10 Market Forecast (2026-2034)
12.5 Tohoku Region
- 12.5.1 Overview
- 12.5.2 Historical and Current Market Trends (2020-2025)
- 12.5.3 Market Breakup by Component
- 12.5.4 Market Breakup by Product
- 12.5.5 Market Breakup by Technology
- 12.5.6 Market Breakup by Procedure
- 12.5.7 Market Breakup by Application
- 12.5.8 Market Breakup by End User
- 12.5.9 Key Players
- 12.5.10 Market Forecast (2026-2034)
12.6 Chugoku Region
- 12.6.1 Overview
- 12.6.2 Historical and Current Market Trends (2020-2025)
- 12.6.3 Market Breakup by Component
- 12.6.4 Market Breakup by Product
- 12.6.5 Market Breakup by Technology
- 12.6.6 Market Breakup by Procedure
- 12.6.7 Market Breakup by Application
- 12.6.8 Market Breakup by End User
- 12.6.9 Key Players
- 12.6.10 Market Forecast (2026-2034)
12.7 Hokkaido Region
- 12.7.1 Overview
- 12.7.2 Historical and Current Market Trends (2020-2025)
- 12.7.3 Market Breakup by Component
- 12.7.4 Market Breakup by Product
- 12.7.5 Market Breakup by Technology
- 12.7.6 Market Breakup by Procedure
- 12.7.7 Market Breakup by Application
- 12.7.8 Market Breakup by End User
- 12.7.9 Key Players
- 12.7.10 Market Forecast (2026-2034)
12.8 Shikoku Region
- 12.8.1 Overview
- 12.8.2 Historical and Current Market Trends (2020-2025)
- 12.8.3 Market Breakup by Component
- 12.8.4 Market Breakup by Product
- 12.8.5 Market Breakup by Technology
- 12.8.6 Market Breakup by Procedure
- 12.8.7 Market Breakup by Application
- 12.8.8 Market Breakup by End User
- 12.8.9 Key Players
- 12.8.10 Market Forecast (2026-2034)

13 Japan Apheresis Market - Competitive Landscape

13.1 Overview
13.2 Market Structure
13.3 Market Player Positioning
13.4 Top Winning Strategies
13.5 Competitive Dashboard
13.6 Company Evaluation Quadrant

14 Profiles of Key Players

14.1 Company A
- 14.1.1 Business Overview
- 14.1.2 Product Portfolio
- 14.1.3 Business Strategies
- 14.1.4 SWOT Analysis
- 14.1.5 Major News and Events
14.2 Company B
- 14.2.1 Business Overview
- 14.2.2 Product Portfolio
- 14.2.3 Business Strategies
- 14.2.4 SWOT Analysis
- 14.2.5 Major News and Events
14.3 Company C
- 14.3.1 Business Overview
- 14.3.2 Product Portfolio
- 14.3.3 Business Strategies
- 14.3.4 SWOT Analysis
- 14.3.5 Major News and Events
14.4 Company D
- 14.4.1 Business Overview
- 14.4.2 Product Portfolio
- 14.4.3 Business Strategies
- 14.4.4 SWOT Analysis
- 14.4.5 Major News and Events
14.5 Company E
- 14.5.1 Business Overview
- 14.5.2 Product Portfolio
- 14.5.3 Business Strategies
- 14.5.4 SWOT Analysis
- 14.5.5 Major News and Events

15 Japan Apheresis Market - Industry Analysis

15.1 Drivers, Restraints, and Opportunities
- 15.1.1 Overview
- 15.1.2 Drivers
- 15.1.3 Restraints
- 15.1.4 Opportunities
15.2 Porters Five Forces Analysis
- 15.2.1 Overview
- 15.2.2 Bargaining Power of Buyers
- 15.2.3 Bargaining Power of Suppliers
- 15.2.4 Degree of Competition
- 15.2.5 Threat of New Entrants
- 15.2.6 Threat of Substitutes
15.3 Value Chain Analysis